Randomized, Double-Blind, Placebo-controlled study of encenicline, an α7 nicotinic acetylcholine receptor agonist, as a treatment for cognitive impairment in schizophrenia

Richard S.E. Keefe, Herbert A. Meltzer, Nancy Dgetluck, Maria Gawryl, Gerhard Koenig, Hans J. Moebius, Ilise Lombardo, Dana C. Hilt*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, Double-Blind, Placebo-controlled study of encenicline, an α7 nicotinic acetylcholine receptor agonist, as a treatment for cognitive impairment in schizophrenia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS